Stoke Therapeutics Inc (NASDAQ:STOK) shares, rose in value on Thursday, March 27, with the stock price up by 0.68% to the previous day’s close as strong demand from buyers drove the stock to $7.45.
Actively observing the price movement in the last trading, the stock closed the session at $7.40, falling within a range of $7.29 and $7.56. The value of beta (5-year monthly) was 0.985. Referring to stock’s 52-week performance, its high was $17.58, and the low was $7.18. On the whole, STOK has fluctuated by -9.92% over the past month.
With the market capitalization of Stoke Therapeutics Inc currently standing at about $402.88 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-17.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 91.26M, with a low estimate of 1.5M and a high estimate of 168M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 27.37M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that STOK’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of STOK currently trading nearly -8.04% and -20.22% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.63, while the 7-day volatility ratio is showing 7.15% which for the 30-day chart, stands at 7.23%. Furthermore, Stoke Therapeutics Inc (STOK)’s beta value is 1.05, and its average true range (ATR) is 0.61.
A comparison of Stoke Therapeutics Inc (STOK) with its peers suggests the former has fared considerably weaker in the market. STOK showed an intraday change of 0.68% in last session, and over the past year, it grew by 14.62%%.
Data on historical trading for Stoke Therapeutics Inc (NASDAQ:STOK) indicates that the trading volumes over the past 10 days have averaged 1.16 and over the past 3 months, they’ve averaged 834.36K. According to company’s latest data on outstanding shares, there are 54.03 million shares outstanding.
Nearly 22.98% of Stoke Therapeutics Inc’s shares belong to company insiders and institutional investors own 89.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.71 million shares as on 2025-03-14, resulting in a short ratio of 15.6. According to the data, the short interest in Stoke Therapeutics Inc (STOK) stood at 3201.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 10.09 million. The stock has fallen by -32.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the STOK stock heading into the next quarter.
